Project Number GC-2013352 Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Year 2017 View Full Project Details for Manufacture and testing of GMP grade senicapoc for a Phase 2 clinical trial repurposing for Prodromal & mild AD. Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 7. Early-stage Clinical Drug Development (Phase I and II Clinical Trials) f. Inflammation Researcher and Organization Principal Investigator Olichney, John Principal Investigator First Name John Principal Investigator Last Name Olichney Awardee Organization University of California Davis School of Medicine Awardee State California Contact PI Country United States Project Detail Funding Opportunity Announcement PACT Program FY Overall Cost $434,991 Funding Organization Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Organization Country United States
